2017
DOI: 10.3892/ijmm.2017.3077
|View full text |Cite
|
Sign up to set email alerts
|

NLRC3 promotes host resistance against Pseudomonas aeruginosa-induced keratitis by promoting the degradation of IRAK1

Abstract: Pseudomonas aeruginosa (PA)-induced keratitis is one of the most common and destructive bacterial diseases. The pathogenesis of PA infections is closely associated with excessive inflammatory responses. Nucleotide oligomerization domain (NOD)-like receptor (NLR) family with caspase activation and recruitment domain (CARD) containing 3 (NLRC3) protein has been implicated as a negative regulator of inflammation and antiviral response, but the role of NLRC3 in PA-induced keratitis has not been described. In the p… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

2
18
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 19 publications
(20 citation statements)
references
References 39 publications
2
18
0
Order By: Relevance
“…In the current study, we revealed that silencing of USP22 suppressed phosphorylation level of p65 and IκBα, which indicated USP22 could promote NF-κB activation, therefore increased the pro-inflammatory cytokines expression. Ubiquitination modification has been reported to play great roles in NF-κB activation, and multiple studies showed that ubiquitination regulation is essential for the regulation of progression of PA keratitis [7,8]. In the present research, we found USP22 could remove K48 linked polyubiquitination chain of TRAF6, which is the key adaptor of NF-κB signaling pathway, leading to the stability of TRAF6, and therefore promote NF-κB activation and the downstream pro-inflammatory cytokines production.…”
Section: Discussionsupporting
confidence: 50%
See 1 more Smart Citation
“…In the current study, we revealed that silencing of USP22 suppressed phosphorylation level of p65 and IκBα, which indicated USP22 could promote NF-κB activation, therefore increased the pro-inflammatory cytokines expression. Ubiquitination modification has been reported to play great roles in NF-κB activation, and multiple studies showed that ubiquitination regulation is essential for the regulation of progression of PA keratitis [7,8]. In the present research, we found USP22 could remove K48 linked polyubiquitination chain of TRAF6, which is the key adaptor of NF-κB signaling pathway, leading to the stability of TRAF6, and therefore promote NF-κB activation and the downstream pro-inflammatory cytokines production.…”
Section: Discussionsupporting
confidence: 50%
“…If the substrate is modified by lysine 48(K48) ubiquitin, the target protein will be degraded by proteasome system [6]. Recently, many studies already showed that ubiquitination process is crucial for the is regulation of inflammatory responses in PA-induced keratitis [7,8].…”
Section: Introductionmentioning
confidence: 99%
“…NLRC3, an intracellular member of NLR family, has been reported to be expressed by various immune cell populations, including macrophages, epithelial cell and T cells and suppress inflammatory signaling pathways in innate immune cells [1520]. These pathways include the NF-κB and STING pathways, which are exploited by bacteria or viruses to evade the host immune response and to promote survival [15,16].…”
Section: Introductionmentioning
confidence: 99%
“…For example, Hu et al reported that NLRC3 negatively regulates CD4+ T cells and impacts protective immunity during Mycobacterium tuberculosis infection . Guo et al demonstrated that NLRC3 promotes host resistance against Pseudomonas aeruginosa ‐induced keratitis by promoting the degradation of interleukin 1 receptor associated kinase 1 (IRAK1) . Zha et al revealed that NLRC3 protected against monocrotaline (MCT)‐induced rat pulmonary hypertension (PH) and platelet‐derived growth factor‐BB (PDGF‐BB)‐induced PASMCs proliferation, migration, and inflammation through a mechanism involving PI3K inhibition .…”
Section: Discussionmentioning
confidence: 99%